TABLE 1.
Family | Name | Gene and proteins Increased expression | Cell Location | Condition | Model | Ref. |
---|---|---|---|---|---|---|
Cytokines | MCP−1 | MCP−1 gene | VECs, VICs | HG | 3D model of the human aortic valve | 60 |
Soluble MCP−1 protein | CM | |||||
TNF‐α | TNF‐α gene |
VECs, VICs CM |
||||
IL8 | IL8 gene | |||||
ILl‐β | ILl‐β gene | |||||
ILl‐β | Soluble ILl‐β protein | |||||
Cell adhesion molecules | VCAM−1 | VCAM−1 protein | VECs | HG | 2D | 50 |
VCAM−1 gene | VECs, VICs | HG | 3D | 60 | ||
VCAM−1 protein | Aortic valve | Early DM | HLD mouse | 41 | ||
ICAM−1 | ICAM−1 protein | |||||
P‐selectin | P‐selectin protein | |||||
E‐selectin | E‐selectin protein | VECs | HG | 2D | 60 | |
E‐selectin gene | VECs, VICs | HG | 3D | 60 | ||
IC α4 | IC α4 gene | VECs | ||||
IC αv | IC αv gene | |||||
IC β1 | IC β1 gene | |||||
IC β3 | IC β3 gene | VECs, VICs | ||||
IC β5 | IC β5 gene | |||||
TGF‐β family members | TGF–β | Soluble TGF–β protein | CM | HG | 3D | |
TGF–β protein | Aortic valve | Early DM | HLD mouse | 41 | ||
BMP−2 | BMP−2 protein | |||||
Soluble BMP−2 | CM | HG | 3D | 59 | ||
BMP−2 gene | VECs, VICs | |||||
BMP−4 | BMP−4 protein | Aortic valve | Early DM | HLD mouse | ||
BMP−4 gene | VECs, VICs | HG | 3D | 60 | ||
Osteogenic molecules | OC | OC protein | Aortic valve | Early DM | HLD mouse | 41 |
OC gene | VICs | HG | 3D | 59 | ||
OP | OP protein | Aortic valve | Early DM | HLD mouse | 41 | |
OP protein | 6‐mo DM | LAI mouse | 40 | |||
OP protein | VICs | βGP | 2D | 44 | ||
OP gene | HG | 3D | 59 | |||
ALP | ALP protein | Aortic valve | DM | DM patients | 60 | |
ALP protein | Early DM | HLD mouse | ||||
ECM proteins | FN | FN protein | Aortic valve | Early DM | HLD mouse | 41 |
LAM | LAM gene | VECs | HG | 3D | 60 | |
COL III | COL III gene | VICs | ||||
MMPs | MMP−2 | MMP−2 protein | Aortic valve | Early DM | HLD mouse | 41 |
MMP−9 | MMP−9 protein | |||||
MMP−1 | MMP−1gene | VICs | HG | 3D | 59 | |
MMP−13 | MMP−13 gene | |||||
SLPGs | BYG | BYG gene | Aortic valve | DM | DM patients | 44 |
BYG protein | ||||||
BYG protein | VICs | βGP | 2D | |||
AGEs | AGEs | AGEs | Aortic valve | DM | DM patients | 46 |
Plasma | ||||||
AGEs receptors | RAGE | RAGE | Human Aortic valve | DM | DM patients | 46 |
Plasma | ||||||
GPs | vWF | vWF gene | VECs | HG | 3D | 60 |
Actin protein family | α‐SMA | α‐SMA protein | Aortic valve | Early DM | HLD mouse | 41 |
S100 family | S100‐A4 | S100‐A4 protein | Aortic valve | Early DM | HLD mouse | 41 |
Annexins | ANXII | ANXII protein | Aortic valve | DM | DM patients | 5 |
TX factors | RUNX−2 | RUNX−2 protein | Aortic valve | DM | DM patients | 5 |
RUNX−2 gene | VECs, VICs | HG | 3D | |||
RUNX−2 protein | VICs | 59 | ||||
Signal transducers | pSMAD1/5/8/9 | pSMAD1/5/8/9 protein | VICs | HG | 3D | 59 |
pSMAD 2/3 | pSMAD 2/3protein | VECs, VICs | ||||
pPKC | pPKC protein | 60 |
Abbreviations: 2D, Two‐dimensional model; 3D, Three‐dimensional model; AGEs, Advanced glycation end products; ALP, Alkaline phosphatase; ANX, Annexin; BMP, Bone morphogenetic protein; BYG, Biglycan; CM, Conditioned media; COL III, Type III collagen; DM, Diabetes mellitus; FN, Fibronectin; HG, High‐glucose media; HLD, Hyperlipemic diabetic; IC, Integrin chain; ICAM‐1, Intercellular adhesion molecule 1; IL‐1β, Interleukin 1 beta; IL‐8, Interleukin 8; LAI, Diabetes mellitus‐prone LDLr−/−/ApoB100/100/IGF‐II; LAM, Laminin gamma chain; MCP‐1, Monocyte chemoattractant protein1; MMP, Matrix metalloproteinase; OC, Osteocalcin; OP, Osteopontin; pPKC, Phosphorylated protein kinase C; pSMAD, Phosphorylated SMAD; RAGE, AGE receptor; Ref, Reference cited; RUNX‐2, Runt‐related transcription factor 2; S100‐A4, S100 calcium‐binding protein A4; SLPGs, Small leucine‐rich proteoglycans; TGF‐β, Transforming growth factor beta; TNF‐α, Tumor necrosis factor alpha; TX, Transcription; VCAM‐1, Vascular cell adhesion molecule 1; VECs, Valvular endothelial cells; VICs, Valvular interstitial cells; vWF, Von Willebrand factor; α‐SMA, α‐ smooth muscle actin; βGP, β‐Glycero‐phosphate stimulation.